14th European Congress of Clinical Microbiology and Infectious ...
14th European Congress of Clinical Microbiology and Infectious ...
14th European Congress of Clinical Microbiology and Infectious ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Poster Sessions Monday, May 3, 2004<br />
P1039 Pharmacokinetics <strong>and</strong> tissue penetration<br />
<strong>of</strong> linezolid in patients with diabetic foot<br />
infection<br />
G. Haase, M. Sass, J. Majcher-Peszynska,<br />
S.C. Müller, R.G. Mundkowski, W. Schareck,<br />
B. Drewelow (Rostock, D)<br />
P1040 Evaluation <strong>of</strong> tigecycline, linezolid,<br />
quinupristin-dalfopristin, arbekacin <strong>and</strong><br />
daptomycin alone <strong>and</strong> in combination with<br />
various antimicrobials against two clinical<br />
strains <strong>of</strong> vancomycin-resistant Staphylococcus<br />
aureus in an in vitro pharmacodynamic model<br />
V. Huang, W. Brown, M. Rybak (Detroit, USA)<br />
P1041 Evaluation <strong>of</strong> cefepime, arbekacin,<br />
daptomycin, gentamicin, tobramycin, <strong>and</strong><br />
tigecycline alone <strong>and</strong> in combination against<br />
methicillin-resistant Staphylococcus aureus in<br />
an in vitro pharmacodynamic infection model<br />
V. Huang, M. Rybak (Detroit, USA)<br />
P1042 Simultaneous methicillin-resistant Staphylococcus<br />
aureus & vancomycin-resistant<br />
Enterococcus faecalis infections in an in vitro<br />
pharmacodynamic model: a comparison<br />
<strong>of</strong> daptomycin, arbekacin, linezolid <strong>and</strong><br />
tigecycline activities<br />
K. Tedesco, M. Rybak (Detroit, USA)<br />
P1043 Pharmacodynamics <strong>of</strong> amoxicillin/clavulanic<br />
acid against Haemophilus influenzae in an in<br />
vitro kinetic model: a comparison <strong>of</strong> different<br />
dosage regimens including a pharmacokinetically<br />
enhanced formulation<br />
E. Löwdin, O. Cars, I. Odenholt (Uppsala, S)<br />
P1044 The comparative antibacterial effect <strong>of</strong><br />
ertapenem <strong>and</strong> ceftriaxone on E. coli studied<br />
in an in vitro pharmacokinetic model <strong>of</strong><br />
infection<br />
K. Bowker, A. Noel, A. MacGowan (Bristol, UK)<br />
P1045 Comparison <strong>of</strong> ertapenem, ampicillin, <strong>and</strong><br />
meropenem against the intracellular forms <strong>of</strong><br />
Listeria monocytogenes in human THP-1<br />
macrophages<br />
S. Lemaire, S. Van de Velde, S. Carryn, F. Van<br />
Bambeke, M.P. Mingeot-Leclercq, P. Tulkens<br />
(Brussels, B)<br />
P1046 Pharmacokinetic-pharmacodynamic modeling<br />
<strong>of</strong> activities <strong>of</strong> cefpodoxime <strong>and</strong> cefixime<br />
based on in vivo tissue concentrations <strong>and</strong> in<br />
vitro kill curves<br />
H. Derendorf, P. Liu, K. R<strong>and</strong>, B. Obermann<br />
(Gainesville, USA; Munich, D)<br />
P1047 Single-dose pharmacokinetics <strong>of</strong> cefodizime<br />
in acutely ill elderly patients<br />
B. Meyer, F. Traunmueller, T. Staudinger,<br />
G. Locker, R. Schmid, F. Thalhammer (Vienna, A)<br />
P1048 Comparative effects <strong>of</strong> ertapenem <strong>and</strong><br />
ceftriaxone on the normal intestinal<br />
micr<strong>of</strong>lora<br />
M.W.R. Pletz, M. Rau, A. de Roux, O. Burkhardt,<br />
M. Kurowski, H. Lode, C.E. Nord<br />
(Berlin, D; Stockholm, S)<br />
P1049 Multiple dose <strong>and</strong> steady-state pharmacokinetics<br />
<strong>of</strong> ertapenem compared to ceftriaxone<br />
in healthy young male <strong>and</strong> female volunteers<br />
M. Rau, M.W.R. Pletz, J. Bulitta, A. de Roux,<br />
G. Schreiber, C.E. Nord, M. Kurowski, G. Kruse,<br />
H. Lode (Berlin, Nuremburg, D; Stockholm, S)<br />
12:00–13:00<br />
Pathogenesis<br />
P1050 Bacterial inhibition <strong>of</strong> phosphatidylcholine<br />
synthesis induces apoptosis in brain cells<br />
J. Zweigner, S. Jackowski, S. Smith,<br />
M. van der Merwe, J. Weber, E. Tuomanen<br />
(Berlin, D; Memphis, USA)<br />
P1051 Bacterial cell-wall derived products induce<br />
a pro-inflammatory <strong>and</strong> pro-fibrogenetic<br />
phenotype in murine hepatic stellate cells<br />
P. Brun, D. Martines, M. Pinzani, G. Palù,<br />
I. Castagliuolo (Padua, I)<br />
P1052 Lipopolysaccharide-induced vascular<br />
endothelial growth factor expression<br />
A.J. Huh, Y.A. Kim, Y.W. Kim, J.S. Yeom,<br />
Y.G. Song, K.H. Chang, J.M. Kim<br />
(Go-yang, Seoul, KOR)<br />
P1053 Antistaphylococcal effect <strong>of</strong> recombinant<br />
human erythropoietin<br />
H. Baskin, Y. Baskin, Y. Dogan, I.H. Bahar<br />
(Izmir, TR)<br />
P1054 Ex vivo release <strong>of</strong> pro-inflammatory cytokines<br />
<strong>of</strong> blood monocytes <strong>of</strong> patients with sepsis:<br />
correlation to the initiation <strong>of</strong> symptoms <strong>and</strong><br />
to monocyte apoptosis<br />
M. Kyriakopoulou, M. Raftogiannis, F. Baziaka,<br />
I. Skiadas, H. Giamarellou, E.J. Giamarellos-<br />
Bourboulis (Athens, GR)<br />
P1055 Adherence factors <strong>of</strong> ocular isolates <strong>of</strong><br />
nontypeable Haemophilus influenzae from<br />
Saudi Arabia<br />
A. Adlan, J.N. Fletcher, A.A. Al-Rajhi, A. Al-Theeb,<br />
A.M. Snelling (Riyadh, SA; Bradford, UK)<br />
P1056 Genetic relationships among nontypable<br />
Haemophilus influenzae isolates presenting<br />
different adhesins pr<strong>of</strong>iles<br />
B. Rybak, E. Augustynowicz, A. Gzyl, G. Gniadek,<br />
J. Slusarczyk, A. Samet (Gdansk, Warsaw, PL)<br />
www.escmid.org/eccmid2004<br />
page 99
Change language